{"transactions":[{"id":723594,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T20:44:26.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date."}],"balance_after":35000,"derivative":{"exercise_price":4.7,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001931514-26-000002","document":"form4-06292026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000193151426000002/form4-06292026_080620.xml","form_type":"4"}},{"id":1098906,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T21:00:14.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 26, 2026, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date."}],"balance_after":25000,"derivative":{"exercise_price":4.18,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-018521","document":"form4-06302025_050609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588925018521/form4-06302025_050609.xml","form_type":"4"}},{"id":1100381,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:53:28.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025091154/ownership.xml","form_type":"4"}},{"id":1212498,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:20:31.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000029","document":"wk-form4_1741724422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000029/wk-form4_1741724422.xml","form_type":"4"}},{"id":1455372,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-12T20:15:28.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.31,"expiration_date":"2034-07-09","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-24-000083","document":"wk-form4_1720815321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000083/wk-form4_1720815321.xml","form_type":"4"}},{"id":1467896,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T21:05:45.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 25, 2025, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date."}],"balance_after":18000,"derivative":{"exercise_price":16.87,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001415889-24-018349","document":"form4-06272024_090642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907108/000141588924018349/form4-06272024_090642.xml","form_type":"4"}},{"id":1847999,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:12:04.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-23-000074","document":"wk-form4_1687389110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000074/wk-form4_1687389110.xml","form_type":"4"}},{"id":2207122,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:19.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026137/doc4.xml","form_type":"4"}}]}